SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008874
Filing Date
2017-08-10
Accepted
2017-08-10 15:52:20
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 451357
2 image_001.jpg GRAPHIC 8802
3 ex31-1.htm EX-31.1 17369
4 ex32-1.htm EX-32.1 7417
  Complete submission text file 0001493152-17-008874.txt   2946649

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE endv-20170630.xml EX-101.INS 504812
6 XBRL SCHEMA FILE endv-20170630.xsd EX-101.SCH 37246
7 XBRL CALCULATION FILE endv-20170630_cal.xml EX-101.CAL 38468
8 XBRL DEFINITION FILE endv-20170630_def.xml EX-101.DEF 141080
9 XBRL LABEL FILE endv-20170630_lab.xml EX-101.LAB 281619
10 XBRL PRESENTATION FILE endv-20170630_pre.xml EX-101.PRE 217486
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55453 | Film No.: 171021387
SIC: 2834 Pharmaceutical Preparations